A/s Genmab, 10% Owner at Merus N.V. (MRUS), bought 1,055,784 shares at $97.00 ($102.4M) on 2025-12-29, disclosed to the SEC on 2025-12-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $97.00 | 2,978 | $289K | 0.3% |
| 2 | $97.00 | 1,052,806 | $102.1M | 99.7% |
| Total | $97.00 avg | 1,055,784 | $102.4M | 100% |
| Filing → |
| MRUS | BUY | 2025-12-18 | $26.3M | — | Filing → |